Mode
Text Size
Log in / Sign up

One-stage revision shows comparable infection control to two-stage revision in chronic periprosthetic joint infection.

One-stage revision shows comparable infection control to two-stage revision in chronic periprostheti…
Photo by National Cancer Institute / Unsplash
Key Takeaway
Consider one-stage revision for chronic PJI given comparable infection control and reduced treatment burden compared to two-stage revision.

This retrospective cohort study examined patients with chronic periprosthetic joint infection who underwent surgical treatment at an orthopedic center. The analysis compared a one-stage revision group (n=16) against a two-stage revision group (n=27). The primary outcome assessed infection control rates at 24 months postoperatively, with secondary outcomes including Harris hip score, Knee Society Score, and incidence of postoperative complications within 90 days. The mean follow-up duration was 29.5 ± 4.5 months.

Results indicated that infection control rates at 24 months were comparable between the two approaches, with one-stage revision achieving 87.5% (14/16) and two-stage revision achieving 88.9% (24/27); the difference was not statistically significant (P = 0.89). Regarding functional outcomes, the one-stage group demonstrated significantly greater improvement in Harris hip score (52.8 ± 6.3 to 85.2 ± 5.1) compared to the two-stage group (55.1 ± 5.9 to 80.4 ± 6.7) (P = 0.021). Similarly, Knee Society Score improvement was significantly greater in the one-stage group (54.3 ± 6.5 to 84.7 ± 5.8) versus the two-stage group (56.4 ± 7.0 to 81.2 ± 6.9) (P = 0.032).

Postoperative complication rates within 90 days showed no significant difference between groups, with one-stage revision reporting 18.75% (3/16) and two-stage revision reporting 14.81% (4/27) (P > 0.05). No serious adverse events were reported. The study noted limitations associated with the prolonged treatment cycle and heavy medical burden inherent to two-stage revision. Funding sources and conflicts of interest were not reported. The authors suggest that one-stage revision may effectively avoid a second surgery, shorten the treatment cycle, and reduce patient suffering and economic burden.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study aims to compare the short-term clinical outcomes of one-stage and two-stage revision surgeries for treating chronic periprosthetic joint infection (PJI), addressing the limitations of the prolonged treatment cycle and heavy medical burden associated with two-stage revision, and evaluating the feasibility and effectiveness of one-stage revision as an alternative therapeutic strategy.MethodsThis retrospective cohort study included PJI patients who underwent surgical treatment at our orthopedic center from July 2018 to November 2023. Patients were divided into one-stage revision group (n=16) and two-stage revision group (n=27) based on the surgical approach. The primary outcome was the infection control rate at 24 months postoperatively, while secondary outcomes included Harris hip score(HHS), Knee Society Score (KSS), and the incidence of postoperative complications within 90 days.ResultsThere were no significant differences between the two groups in baseline characteristics. The mean follow-up duration was 29.5 ± 4.5 months. The infection control rate was comparable between one-stage (87.5%, 14/16) and two-stage (88.9%, 24/27) revision (P = 0.89). For hip function, HHS improved from 52.8 ± 6.3 to 85.2 ± 5.1 in the one-stage group and from 55.1 ± 5.9 to 80.4 ± 6.7 in the two-stage group. For knee function, KSS improved from 54.3 ± 6.5 to 84.7 ± 5.8 in the one-stage group and from 56.4 ± 7.0 to 81.2 ± 6.9 in the two-stage group. The one-stage group demonstrated significantly greater functional improvement in both HHS (P = 0.021) and KSS (P = 0.032). Postoperative complication rates were 18.75% (3/16) and 14.81% (4/27), respectively (P>0.05).ConclusionIn PJI patients with clear preoperative pathogen identification, one-stage revision surgery demonstrates comparable infection control rates and safety to two-stage revision after two years of follow-up, with superior joint function recovery. One-stage revision can effectively avoid a second surgery, shorten the treatment cycle, and reduce patient suffering and economic burden, making it an effective treatment option for eligible PJI patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.